India’s pharmaceutical company Zydus begins human trails for potential COVID vaccine

Srinagar: Indian pharmaceutical company Zydus on Wednesday said that it has started human studies for its potential COVID vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation, reports said.

According to a report by an international news agency Reuters, ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

The report added that in the human trials, Zydus will enroll over 1,000 subjects across multiple clinical study sites in India.

On Tuesday, India recorded a spike of more than 28,000 cases for the second consecutive day in the last 24 hours, pushing the tally to 9,06,752 cases with a death total of 23,727.

India crossed nine lakh mark from eight lakh within three days. It had crossed the 8 lakh Covid-19 cases on July 11. India witnessed a spike of 28,498 fresh cases and with 553 deaths in the last 24 hours the total number of fatalities crossed 23,727.

Free Press Kashmir is now on Telegram. Click here to Join.